StatementofWork2024.docx
DOCX document 16 KB Posted
- Attached to
- National Drug Data File Renewal Federal contract opportunity
- Solicitation number
- CMMI-393-2024-0078-RAW
About this file
This document is a Statement of Work (SOW) for a federal contract opportunity to renew the license agreements for continued access to the First Databank (FDB) data.
The SOW states that the purpose of this acquisition is to renew the license agreements for FDB data, which includes a complete line of drug databases, clinical decision support, disease suite modules, and stand-alone PC products. FDB data provides descriptive drug information, drug pricing, and drug identification that CMS uses for intramural research and analysis projects related to Medicare and Medicaid programs. The period of performance is July 15, 2024 to July 14, 2025.
The related federal contract opportunity is a sole source solicitation (CMMI-393-2024-0078-RAW) for the National Drug Data File (NDDF) renewal, as FDB is the only source for this data that CMS requires for its research. All responsible sources may submit capability statements, proposals, or quotations by May 24, 2024. The NAICS code is 51140 (Director and Mailing List Publishers) with a size standard of 500 employees.
View the file
Other files for this federal contract opportunity
| File | Type | Posted |
|---|---|---|
| RFQ-FDB.docx | DOCX document |
On GovTribe
Work with this file on GovTribe
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
STATEMENT OF WORK
February 6, 2024
Purpose:
The purpose of this acquisition is to renew the license agreements for continued access to the First Databank (FDB) data.
Background:
FDB is a publisher of pharmaceutical information that is used within healthcare information systems serving hospitals, physician practices, other providers, payers, retail pharmacies, state health programs and others for the purpose of medication decision support and negotiating reimbursement rates paid to pharmacies and other providers. FDB data include a complete line of drug databases, including clinical decision support, disease suite modules, and stand-alone PC products. These data also include descriptive drug information, drug pricing, and drug identification. CMS uses the FDB files for intramural research and analysis projects related to Medicare and Medicaid programs.
Task:
FDB will renew CMS’s license for the FDB data files for three years. As part of this license renewal, FDB will provide data files to CMS via a secure website on a weekly basis and allow the data to be used for up to 10 projects for each year.
Period of Performance:
07/15/2024 – 07/14/2025
File details come from the government source that posted it. Updated .